No Data
No Data
Petros Pharmaceuticals Approves Key Amendments to Incorporation
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Petros Pharmaceuticals Full Year 2024 Earnings: US$3.34 Loss per Share (Vs US$6.35 Loss in FY 2023)
Petros Pharmaceuticals | 10-K: FY2024 Annual Report
Trending Stocks Today | Petros Pharmaceuticals Surges 225.25%
browny_440 : we won't take less than $1 so bye-bye